BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 26523112)

  • 1. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
    Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
    World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Prior JO; Bertagna F; Ceriani L; Giovanella L
    Lung Cancer; 2014 Jan; 83(1):1-7. PubMed ID: 24290256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis.
    Treglia G; Quartuccio N; Sadeghi R; Farchione A; Caldarella C; Bertagna F; Fania P; Cistaro A
    J Crohns Colitis; 2013 Jun; 7(5):345-54. PubMed ID: 22960135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L
    Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
    Treglia G; Kakhki VR; Giovanella L; Sadeghi R
    Am J Clin Dermatol; 2013 Dec; 14(6):437-47. PubMed ID: 23959776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Caldarella C; Bertagna F; Giovanella L
    Biomed Res Int; 2014; 2014():852681. PubMed ID: 24963486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.
    Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J
    Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis.
    Jin H; Yuan L; Li C; Kan Y; Hao R; Yang J
    Q J Nucl Med Mol Imaging; 2014 Mar; 58(1):85-93. PubMed ID: 24469570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis.
    Annunziata S; Caldarella C; Pizzuto DA; Galiandro F; Sadeghi R; Giovanella L; Treglia G
    Biomed Res Int; 2014; 2014():247693. PubMed ID: 24955351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
    Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L
    Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Positron tomography with 18F-fluorodeoxyglucose in the preoperative evaluation of gall bladder lesions suspicious of malignancy. Diagnostic utility and clinical impact].
    Ramos-Font C; Gómez Río M; Rodríguez-Fernández A; Sánchez Sánchez R; Llamas Elvira JM
    Rev Esp Med Nucl; 2011; 30(5):267-75. PubMed ID: 21612846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis.
    Zhang Q; Feng H; Li J; Feng R
    J Orthop Surg Res; 2023 Jan; 18(1):23. PubMed ID: 36627651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y; Wang L; Jiang X; She W; He L; Hu G
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of FDG-PET/CT in the detection of gallbladder cancer.
    Ramos-Font C; Gómez-Rio M; Rodríguez-Fernández A; Jiménez-Heffernan A; Sánchez Sánchez R; Llamas-Elvira JM
    J Surg Oncol; 2014 Mar; 109(3):218-24. PubMed ID: 24165875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.